EXECUTIVE ENGAGEMENTS
POOL
INTERACTIONS
PARTICIPANTS
VALIDATIONS
COMPANIES
* Login for a full stack data experience
DATE
JAN 2023
TABLES
122
PAGES
216
EDITION
20
PRICE
USD 5450
CODE
MCP-7877
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
What`s New for 2023?
»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
»Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
»Online interactive peer-to-peer collaborative bespoke updates
»Access to our digital archives and MarketGlass Research Platform
»Complimentary updates for one year
Looking Ahead to 2023
The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Global Personalized Medicines Market to Reach $740.3 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Personalized Medicines estimated at US$1.1 Trillion in the year 2022, is projected to reach a revised size of US$740.3 Billion by 2030, growing at a CAGR of -5% over the analysis period 2022-2030. Personalized Nutrition & Wellness, one of the segments analyzed in the report, is projected to record a -5.1% CAGR and reach US$437.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Personalized Medical Care segment is readjusted to a revised -4.7% CAGR for the next 8-year period.
The U.S. Market is Estimated at $329.3 Billion, While China is Forecast to Grow at -5.2% CAGR
The Personalized Medicines market in the U.S. is estimated at US$329.3 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$130.3 Billion by the year 2030 trailing a CAGR of -5.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at -5.4% and -5.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately -5.9% CAGR.
SELECT PLAYERS
Abbott Molecular; Beckman Coulter, Inc.; bioMérieux SA; Bristol-Myers Squibb Company; Dako Denmark A/S; F. Hoffmann-La Roche Ltd.; GlaxoSmithKline Plc; Hologic, Inc.; Lab 21 Limited; Macrogen, Inc.; NeoGenomics Laboratories, Inc.; Novartis AG; QIAGEN NV; Rosetta Genomics Ltd.; Thermo Fischer Scientific Inc.
SEGMENTS
» Product (Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics, Personalized Medicine Therapeutics)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
I. METHODOLOGY |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Influencer Market Insights |
World Market Trajectories |
Access to Valuable Genetic Information Ushers Transformation in Medicine |
Recent Market Activity |
Market Outlook |
Adoption of Personalized Medicines - A Peek into Developed and Developing Economies |
Increasing Market Availability of Personalized Medicines |
Select Key Approved Personalized Medicines and Associated Biomarkers by Therapeutic Area |
Constraints in Traditional Approach to Treatment Creates Need and Demand for Personalized Medicine |
Economics of Personalized Medicine |
Is Emergence of Personalized Medicine Signaling the End of Blockbusters? |
Personalized Medicines – Global Key Competitors Percentage Market Share in 2022 (E) |
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
Impact of Covid-19 and a Looming Global Recession |
2. FOCUS ON SELECT PLAYERS |
Abbott Molecular, Inc. (USA) |
Beckman Coulter Genomics (USA) |
bioMérieux SA (France) |
Bristol-Myers Squibb Company (USA) |
Dako Denmark A/S (Denmark) |
F. Hoffmann-La Roche Ltd. (Switzerland) |
GlaxoSmithKline plc. (UK) |
Hologic, Inc. (USA) |
Lab 21 Limited (UK) |
Macrogen, Inc. (Korea) |
NeoGenomics Laboratories, Inc. (USA) |
Novartis AG (Switzerland) |
QIAGEN NV (The Netherlands) |
Rosetta Genomics Ltd (Israel) |
Thermo Fisher Scientific Inc. (USA) |
3. MARKET TRENDS & DRIVERS |
Growth Drivers in a Gist |
Key Market Restraints |
Increasing Incidence and Prevalence of CDDs: A Major Growth Driver |
Oncology - A Major Application Market |
Diagnosed Cases of Cancer on the Rise |
World Cancer Statistics: Incidence and Mortality Data |
Growing Cancer Cases in Developing Countries Bodes Well for the Personalized Medicine Market |
Growing Importance of Personalized Drugs for Cancer Treatment |
Ballooning Global Population Offers Significant Growth Opportunities |
Aging Global Population Drives Personalized Medicines |
Increasing Healthcare Spending in Emerging Markets |
Changing Patients' Trends Drive Personalized Medicine |
Technological Advancements and Consumer Push to Drive Personalized Medicine |
Minimizing Adverse Events - A Major Benefit of Personalized Medicines |
Personalized Medicines Brings Disease Prevention Closer to Reality |
Ability to Manage Healthcare Costs Piques Industry and Government Alike |
Potential to Uncover Additional Prospective Targets - A Major Benefit in Pursuit |
Elimination of Invasive Tests Attracts Patients and Doctors towards Molecular Test-based Personalized Medicines |
Genomics to Dictate Advancement of Personalized Medicines |
Companion Diagnostics Drive Personalized Medicine |
Biomarkers as Companion Diagnostics |
Personalized Medicines Help Reducing R&D Costs |
Personalized Medicine - A Corporate Growth Strategy |
Development Pipeline Reveals Promising Picture for Personalized Medicine |
Advancements in Biomedical Imaging to Enhance Personalized Medicines |
Increasing Use of Personalized Medicines Drives Genetic Testing |
Genetic Testing: The Rapidly Growing Segment of Molecular Diagnostics Market |
Next-Generation Sequencing - A Giant Leap in Genome Sequencing |
Single Nucleotide Polymorphism (SNP) - Making Advancements in Personalized Medicine |
Personalized Medicine Goes Beyond DNA Analysis |
Combination Approaches May Mark Future Endeavors |
Need for New Designs in Clinical Trials Emerges in Therapies for Rare Cancers |
Immunotherapy for Cancers - A Potential Breakthrough in the Sector |
Personalized Medicine Industry - Inundated with Data |
Advanced Computing Technologies - The Need of The Hour to Analyze Large Data |
Artificial Intelligence Revolutionizing Personalized Medicine |
Challenges Aplenty for Precision Medicine |
Lack of Clinically Useful Diagnostic Tests - Growth Dampener |
Pricing and Value Dilemma Haunts Personalized Medicines |
Bedside Biopharmaceutical Production to Dramatically Reduce Cost of Personalized Medicine |
4. GLOBAL MARKET PERSPECTIVE |
World Recent Past, Current & Future Analysis for Personalized Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Personalized Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Personalized Medicines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Personalized Nutrition & Wellness by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Personalized Nutrition & Wellness by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Personalized Nutrition & Wellness by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Personalized Medical Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Personalized Medical Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Personalized Medical Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Personalized Medicine Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Personalized Medicine Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Personalized Medicine Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Personalized Medicine Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Personalized Medicine Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Personalized Medicine Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Personalized Medicines Market Analysis of Annual Sales in US$ Million for Years 2012 through 2027 |
III. MARKET ANALYSIS |
UNITED STATES |
Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E) |
USA Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2021 & 2027 |
CANADA |
Canada Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2021 & 2027 |
JAPAN |
Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E) |
Japan Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2021 & 2027 |
CHINA |
Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E) |
China Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
China Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2021 & 2027 |
EUROPE |
Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E) |
Europe Recent Past, Current & Future Analysis for Personalized Medicines by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
Europe Historic Review for Personalized Medicines by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Personalized Medicines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2021 & 2027 |
FRANCE |
Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E) |
France Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
France Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2021 & 2027 |
GERMANY |
Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E) |
Germany Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2021 & 2027 |
ITALY |
Italy Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2021 & 2027 |
UNITED KINGDOM |
Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E) |
UK Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2021 & 2027 |
REST OF EUROPE |
Rest of Europe Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2021 & 2027 |
ASIA-PACIFIC |
Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E) |
Asia-Pacific Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2021 & 2027 |
REST OF WORLD |
Rest of World Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of World Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of World 15-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2021 & 2027 |
IV. COMPETITION |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com